Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Clover Health vs. Wendy's: Which Meme Stock is a Better Buy?

Published 06/16/2021, 12:11 PM
Updated 06/16/2021, 01:30 PM
© Reuters.  Clover Health vs. Wendy's: Which Meme Stock is a Better Buy?

With the meme stock craze showing no sign of fading, two recent additions—Clover Health (CLOV) and Wendy’s (WEN)—saw their share prices spike to crazy highs last week. However, given the increased volatility of meme stocks, investors are increasingly unsure how long their momentum could last. As such, we think it’s best to bet on names that possess strong financials and business models to help sustain their rallies. So, with that in mind, let’s evaluate which of these two stocks is a better buy now.As the Reddit-fueled meme stock mania intensifies, it seems that retail traders have now shifted their focus from AMC Entertainment Holdings (NYSE:AMC) and GameStop Corporation (NYSE:GME) to several new names that include Clover Health Investments, Corp. (CLOV) and The Wendy's Company (NASDAQ:WEN). The price of healthcare company CLOV’s stock jumped a staggering 109% on June 8 as amateur traders on social media platforms continued to drive rallies in heavily shorted U.S. stocks. Similarly, WEN’s shares surged nearly 26% to record highs on the same day after subreddit r/wallstreetbets forum’s post pitched the fast-food-joint as “the perfect stock” because of its signature products and “effective” social media presence.

However, CLOV’s shares have crashed into negative territory. The stock has lost 37.8% over the past five days. This reflects that the gains were not a result of financial performance and fundamentals, but merely social media attention. In contrast, WEN has been witnessing strong digital and store sales, and increasing demand for its premium food items. Since the company is both fundamentally and financially sound, it could continue to see solid gains going forward.

While CLOV has gained 84.3% over the past month, WEN has returned 1.4%. In terms of past three months’ performance, CLOV is the clear winner with 55.2% gains versus WEN’s 10.2% returns. But which of these stocks is a better pick now? Let’s find out.

Continue reading on StockNews

Latest comments

Neither of them are good. It's P&D driven by the media. The meme stocks they tell you to forget about? Now that's the right investment. GME and AMC are literally on blast daily with no real and honest bearish DD in sight.  You can try ignoring them further, sure. But they aren't going anywhere.
Buy and turn Grey in couple of days hahaha💎👐🐒🚀🚀🚀
neither both these are pump and dumps. FUD and hodl.
No they didn´t. Still holding on AMC and GME - fud news
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.